Our MWAS on the aggregate effects of non-MHC MS susceptibility loci (non-MHC polygenic score) on DNA methylation in CD4+ T cells did not result in any significant finding (all FDR-adjusted p > 0.05). Here, CD4 is linked to myeloid sarcoma.